Vitamin K is mainly known as an agent involved in blood coagulation, maintaining the activity of coagulation factors in the liver. In addition, epidemiological studies suggested that a lack of vitamin K is associated with several diseases, including osteoporosis and vascular calcification. There are two main kinds of vitamin K: Phylloquinone (or PK) and Menaquinones (MKn), both act as co-enzyme of y-glutamyl carboxylase (GGCX) transforming under-carboxylated in carboxylated vitamin K dependent proteins, such as Bone Gla Protein (or Osteocalcin) and Matrix Gla Protein. Recently, Vitamin K was also identified as a ligand of the nuclear steroid and xenobiotic receptor (SXR) (in murine species Pregnane X Receptor: PXR), expressed in osteoblasts. The purpose of this literature review is to evaluate the protective role of Vitamin K in bone and vascular health.
CITATION STYLE
Fusaro, M., Mereu, M. C., Aghi, A., Iervasi, G., & Gallieni, M. (2017, August 1). Vitamin K and bone. Clinical Cases in Mineral and Bone Metabolism. CIC Edizioni Internazionali s.r.l. https://doi.org/10.11138/CCMBM/2017.14.1.200
Mendeley helps you to discover research relevant for your work.